Lisa Scholz, Sentry’s Head of Industry Relations, has published an article in Specialty Pharmacy Times. The article discusses the effect that the January CMS 340B reimbursement cuts have had on safety-net hospitals and offers suggestions for how hospital pharmacies can maximize revenue in the face of the 340B cuts.

Lisa has been an expert on the 340B program throughout her career, having previously served as both vice president of the HRSA Pharmacy Services Support Center at the American Pharmacists Association and as chief operating officer and senior vice president at 340B Health.

Read the article: The Brave New World of 340B: Where do we go From Here?